ロード中...
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
AIMS/HYPOTHESIS: The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes. The present study aims to evaluate a novel molecule with a dual action against the metabolic syndrome and type 2 diabetes. METHODS: We developed and tested a novel dual modulator, RB394, whi...
保存先:
| 出版年: | Diabetologia |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563928/ https://ncbi.nlm.nih.gov/pubmed/30032428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-018-4685-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|